These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21106724)

  • 41. The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients.
    Dragonas C; Wagner JT; Heppner HJ; Bertsch T; Muhlberg W; Wicklein S; Pahl A; Diewald C; Bachmakov I; Sieber CC; Fromm MF
    Eur J Clin Pharmacol; 2008 Apr; 64(4):367-72. PubMed ID: 18080812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (ABCG2, ABCB1) and gefitinib toxicity.
    Tamura M; Kondo M; Horio M; Ando M; Saito H; Yamamoto M; Horio Y; Hasegawa Y
    Nagoya J Med Sci; 2012 Feb; 74(1-2):133-40. PubMed ID: 22515119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder.
    de Klerk OL; Nolte IM; Bet PM; Bosker FJ; Snieder H; den Boer JA; Bruggeman R; Hoogendijk WJ; Penninx BW
    Pharmacogenomics J; 2013 Aug; 13(4):349-53. PubMed ID: 22641028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms.
    Natarajan K; Bhullar J; Shukla S; Burcu M; Chen ZS; Ambudkar SV; Baer MR
    Biochem Pharmacol; 2013 Feb; 85(4):514-24. PubMed ID: 23261525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ABCB1 polymorphisms may have a minor effect on ciclosporin blood concentrations in myasthenia gravis patients.
    Zhang YT; Yang LP; Shao H; Li KX; Sun CH; Shi LW
    Br J Clin Pharmacol; 2008 Aug; 66(2):240-6. PubMed ID: 18717915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substrate-dependent effects of human ABCB1 coding polymorphisms.
    Gow JM; Hodges LM; Chinn LW; Kroetz DL
    J Pharmacol Exp Ther; 2008 May; 325(2):435-42. PubMed ID: 18287207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1.
    Yoo HD; Cho HY; Lee SN; Yoon H; Lee YB
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):329-41. PubMed ID: 22623266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.
    Panczyk M; Balcerczak E; Piaskowski S; Jamroziak K; Pasz-Walczak G; Mirowski M
    Int J Colorectal Dis; 2009 Aug; 24(8):895-905. PubMed ID: 19415305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of ABCB1 (1236C > T, 2677G > T and 3435C > T) polymorphisms on the transport ability of P-gp-mediated sunitinib in Caco-2 cell line.
    Tan DQ
    Xenobiotica; 2020 Mar; 50(3):346-353. PubMed ID: 31023123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar.
    Tang SC; Nguyen LN; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Int J Cancer; 2014 Mar; 134(6):1484-94. PubMed ID: 24037730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis.
    Shi XJ; Geng F; Jiao Z; Cui XY; Qiu XY; Zhong MK
    J Clin Pharm Ther; 2011 Oct; 36(5):614-24. PubMed ID: 21916909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. P-glycoprotein Limits Ribociclib Brain Exposure and CYP3A4 Restricts Its Oral Bioavailability.
    Martínez-Chávez A; van Hoppe S; Rosing H; Lebre MC; Tibben M; Beijnen JH; Schinkel AH
    Mol Pharm; 2019 Sep; 16(9):3842-3852. PubMed ID: 31329454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain accumulation of tivozanib is restricted by ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein) in mice.
    Wang J; Bruin MAC; Gan C; Lebre MC; Rosing H; Beijnen JH; Schinkel AH
    Int J Pharm; 2020 May; 581():119277. PubMed ID: 32234426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms.
    Meissner K; Jedlitschky G; Meyer zu Schwabedissen H; Dazert P; Eckel L; Vogelgesang S; Warzok RW; Böhm M; Lehmann C; Wendt M; Cascorbi I; Kroemer HK
    Pharmacogenetics; 2004 Jun; 14(6):381-5. PubMed ID: 15247630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
    Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM
    Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between tacrolimus concentration and genetic polymorphisms of CYP3A5 and ABCB1 during the early stage after liver transplant in an Iranian population.
    Rahsaz M; Azarpira N; Nikeghbalian S; Aghdaie MH; Geramizadeh B; Moini M; Banihashemi M; Darai M; Malekpour Z; Malekhosseini SA
    Exp Clin Transplant; 2012 Feb; 10(1):24-9. PubMed ID: 22309416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promoter Haplotypes of the ABCB1 Gene Encoding the P-Glycoprotein Differentially Affect Its Promoter Activity by Altering Transcription Factor Binding.
    Speidel JT; Xu M; Abdel-Rahman SZ
    DNA Cell Biol; 2018 Dec; 37(12):973-981. PubMed ID: 30277801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?
    Zubiaur P; Saiz-Rodríguez M; Koller D; Ovejero-Benito MC; Wojnicz A; Abad-Santos F
    Pharmacogenomics; 2018 Nov; 19(16):1285-1297. PubMed ID: 30334473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on axitinib brain accumulation and oral plasma pharmacokinetics.
    Poller B; Iusuf D; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Drug Metab Dispos; 2011 May; 39(5):729-35. PubMed ID: 21282407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury.
    Cousar JL; Conley YP; Willyerd FA; Sarnaik AA; Puccio AM; Empey PE; Kochanek PM; Bell MJ; Okonkwo DO; Clark RS
    Neurocrit Care; 2013 Oct; 19(2):192-8. PubMed ID: 23896815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.